Invention Grant
- Patent Title: 3,4-dihydroquinazoline derivative and combination comprising the same
-
Application No.: US15310854Application Date: 2015-05-11
-
Publication No.: US09969697B2Publication Date: 2018-05-15
- Inventor: Jae Yeol Lee , Kyung-Tae Lee
- Applicant: UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
- Applicant Address: KR Yongin-si
- Assignee: UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
- Current Assignee: UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY
- Current Assignee Address: KR Yongin-si
- Agency: Sughrue Mion, PLLC
- Priority: KR10-2014-0062507 20140523
- International Application: PCT/KR2015/004667 WO 20150511
- International Announcement: WO2015/178608 WO 20151126
- Main IPC: C07D239/84
- IPC: C07D239/84 ; A61K31/498 ; C07D239/74 ; A61K31/506 ; A61K31/517 ; A61K31/5377 ; A61K31/704 ; A61K31/7048 ; A61K33/24 ; A61K45/06 ; A61K47/50

Abstract:
A 3,4-dihydroquinazoline derivative or a pharmaceutically acceptable salt thereof and a composition containing the same are provided. The 3,4-dihydroquinazoline derivative or a pharmaceutically acceptable salt thereof show activities of blocking an intracellular influx of calcium ions acting as a secondary signal essential to the proliferation and growth of cancer cells, thereby inducing the cell cycle arrest of cancer cells, and eventually reinforcing the efficacy of existing anti-cancer drugs. A combination comprising the above compound and another anti-cancer drug is also provided.
Public/Granted literature
- US20170081291A1 3,4-DIHYDROQUINAZOLINE DERIVATIVE AND COMBINATION COMPRISING THE SAME Public/Granted day:2017-03-23
Information query